|
Rossari Biotech Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
2806.42 Cr.
|
P/BV
|
2.19
|
Book Value (Rs.)
|
231.78
|
|
52 Week High/Low (Rs.)
|
766/375
|
FV/ML
|
2/1
|
P/E(X)
|
18.81
|
|
Bookclosure
|
20/06/2025
|
EPS (Rs.)
|
26.94
|
Div Yield (%)
|
0.10
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| No. of Equity Shares (in Lacs) | 553.85 | 553.64 | 552.46 | 551.55 | 550.56 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 11.08 | 11.07 | 11.05 | 11.03 | 11.01 |
| Total Share Capital | 11.08 | 11.07 | 11.05 | 11.03 | 11.01 |
| | | | | | |
| Reserves and Surplus | 1322.27 | 1174.38 | 1033.14 | 900.63 | 790.87 |
| Total Reserves and Surplus | 1322.27 | 1174.38 | 1033.14 | 900.63 | 790.87 |
| Employees Stock Options | 0.00 | 0.00 | 3.54 | 3.50 | 3.29 |
| Total Shareholders Funds | 1333.35 | 1185.45 | 1047.73 | 915.17 | 805.16 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 94.33 | 100.03 | 33.32 | 34.93 | 0.00 |
| Deferred Tax Liabilities [Net] | 43.05 | 46.57 | 51.47 | 58.72 | 68.95 |
| Other Long Term Liabilities | 20.25 | 22.31 | 10.91 | 7.39 | 85.03 |
| Long Term Provisions | 8.26 | 5.26 | 3.98 | 4.49 | 2.92 |
| Total Non-Current Liabilities | 165.89 | 174.16 | 99.69 | 105.54 | 156.89 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 313.66 | 87.94 | 72.50 | 39.00 | 8.43 |
| Trade Payables | 323.45 | 286.34 | 219.10 | 185.19 | 186.15 |
| Other Current Liabilities | 144.12 | 154.98 | 128.62 | 120.94 | 98.49 |
| Short Term Provisions | 8.32 | 7.32 | 4.52 | 1.74 | 1.60 |
| Total Current Liabilities | 789.56 | 536.57 | 424.74 | 346.86 | 294.66 |
| | | | | | |
| Total Capital And Liabilities | 2288.79 | 1896.18 | 1572.15 | 1367.57 | 1256.72 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 560.54 | 353.53 | 314.69 | 313.61 | 346.65 |
| Intangible Assets | 105.20 | 126.10 | 144.15 | 151.29 | 170.64 |
| Capital Work-In-Progress | 173.30 | 140.19 | 47.21 | 13.07 | 1.34 |
| Intangible Assets Under Development | 0.00 | 0.00 | 0.00 | 3.01 | 0.00 |
| Fixed Assets | 839.04 | 619.82 | 506.05 | 480.98 | 518.63 |
| Goodwill On Consolidation | 118.71 | 118.71 | 118.71 | 118.71 | 89.86 |
| Non-Current Investments | 27.19 | 26.49 | 25.28 | 25.18 | 24.37 |
| Deferred Tax Assets [Net] | 14.94 | 10.51 | 4.81 | 3.20 | 1.35 |
| Other Non-Current Assets | 45.23 | 77.52 | 72.51 | 18.34 | 13.22 |
| Total Non-Current Assets | 1045.12 | 853.05 | 727.37 | 646.41 | 647.43 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Current Investments | 35.10 | 57.31 | 37.58 | 26.00 | 11.55 |
| Inventories | 404.55 | 355.08 | 282.33 | 188.48 | 189.93 |
| Trade Receivables | 557.41 | 474.50 | 425.13 | 353.66 | 304.85 |
| Cash And Cash Equivalents | 92.21 | 57.16 | 30.21 | 124.57 | 52.35 |
| Short Term Loans And Advances | 1.15 | 1.24 | 0.70 | 0.29 | 1.39 |
| OtherCurrentAssets | 153.25 | 97.83 | 68.83 | 28.16 | 49.22 |
| Total Current Assets | 1243.68 | 1043.14 | 844.79 | 721.16 | 609.29 |
| | | | | | |
| Total Assets | 2288.79 | 1896.18 | 1572.15 | 1367.57 | 1256.72 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 0.00 | 1.98 | 5.44 | 19.96 | 2.61 |
| | | | | | |
| BONUS DETAILS | | | | | |
| Bonus Equity Share Capital | 0.00 | 5.28 | 5.28 | 5.28 | 5.28 |
| | | | | | |
| NON-CURRENT INVESTMENTS | | | | | |
| Non-Current Investments Quoted Market Value | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.20 | 0.20 | 0.20 | 0.20 |
| | | | | | |
| CURRENT INVESTMENTS | | | | | |
| Current Investments Quoted Market Value | 0.00 | 57.31 | 37.58 | 26.00 | 11.55 |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 11.55 |
